Stay updated on Dupilumab in Prurigo Nodularis: Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in Prurigo Nodularis: Clinical Trial page.

Latest updates to the Dupilumab in Prurigo Nodularis: Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedAdded a note clarifying that publications are automatically filled from PubMed and may not be about the study, and updated the page revision to v3.3.2. The previous PubMed-focused note and revision text (v3.2.0) were removed.SummaryDifference0.1%

- Check27 days agoChange DetectedAdded a new publication citation to the Publications section (Kim BS et al., Am J Clin Dermatol, 2025) and removed a generic NIH funding status notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check49 days agoChange DetectedAn updated last update timestamp and minor formatting changes are visible; core study details, eligibility criteria, locations, and outcomes remain unchanged.SummaryDifference0.3%

- Check70 days agoChange DetectedAdded a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.SummaryDifference2%

- Check78 days agoChange DetectedAdd: Revision: v3.1.0 to indicate a new version. Remove: several MedlinePlus topics and an earlier version tag (v3.0.2).SummaryDifference0.3%

- Check85 days agoChange DetectedThe page now includes newer date-related entries and a new “Plain Language Results Summary” link, while older date stamps from 2022 are removed. Overall, content meaning remains largely the same with updated time references.SummaryDifference0.7%

Stay in the know with updates to Dupilumab in Prurigo Nodularis: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in Prurigo Nodularis: Clinical Trial page.